Myelofibrosis: Emerging Therapeutic Strategies and Managing Patients Intolerant/Resistant to Ruxolitinib

Download this slideset for expert perspectives on emerging therapies and optimal management of patients with myelofibrosis that is intolerant/resistant to ruxolitinib.
Raajit K. Rampal, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.14 MB
Released: December 6, 2019


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Celgene Corporation
CTI Biopharma

Related Content

From Clinical Care Options, view this CME-certified video featuring expert perspectives on treatment of patients with myeloproliferative neoplasms

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Physicians: maximum of 2.5 AMA PRA Category 1 Credits Released: January 17, 2020 Expiration: January 16, 2021

Expert answers to key questions on the current treatment of myeloproliferative neoplasms from a Clinical Care Options (CCO) symposium at ASH 2019

Srdan Verstovsek, MD, PhD
Program Director
Jean-Jacques Kiladjian, MD, PhD Raajit K. Rampal, MD, PhD Alessandro M. Vannucchi, MD
Released: January 16, 2020

Data on venetoclax with or without azacitidine in patients with relapsed/refractory MDS from ASH 2019 as reported by Clinical Care Options (CCO)

Released: December 19, 2019

From Clinical Care Options, download slides reviewing the optimal management of MPNs.

Prithviraj Bose, MD Stephen Oh, MD, PhD Released: December 19, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?